ZA200902488B - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
ZA200902488B
ZA200902488B ZA200902488A ZA200902488A ZA200902488B ZA 200902488 B ZA200902488 B ZA 200902488B ZA 200902488 A ZA200902488 A ZA 200902488A ZA 200902488 A ZA200902488 A ZA 200902488A ZA 200902488 B ZA200902488 B ZA 200902488B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
ZA200902488A
Inventor
Yi Gao
R Ju Tzuchi
Dennis Y Lee
Nicole Nguyen
Hauiliang Wu
Original Assignee
Abbott Lab
Fournier Lab Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab, Fournier Lab Ireland Ltd filed Critical Abbott Lab
Publication of ZA200902488B publication Critical patent/ZA200902488B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200902488A 2006-10-12 2007-10-12 Pharmaceutical formulations ZA200902488B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82925506P 2006-10-12 2006-10-12

Publications (1)

Publication Number Publication Date
ZA200902488B true ZA200902488B (en) 2010-10-27

Family

ID=38961056

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200902488A ZA200902488B (en) 2006-10-12 2007-10-12 Pharmaceutical formulations

Country Status (14)

Country Link
EP (1) EP2081563A1 (en)
JP (1) JP2010506855A (en)
KR (1) KR20090119959A (en)
CN (1) CN101677981A (en)
AU (1) AU2007307641A1 (en)
CA (1) CA2672686A1 (en)
CO (1) CO6160302A2 (en)
EA (1) EA200900531A1 (en)
EC (1) ECSP099251A (en)
IL (1) IL198160A0 (en)
MX (1) MX2009003815A (en)
SG (1) SG175570A1 (en)
WO (1) WO2008046052A1 (en)
ZA (1) ZA200902488B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102046153B (en) * 2008-05-30 2015-06-17 Ucb医药有限公司 Pharmaceutical compositions comprising brivaracetam
CN102304103A (en) * 2011-06-03 2012-01-04 郑州泰基鸿诺药物科技有限公司 Fenofibrate acid salt, preparation method, pharmaceutical composition and application
CN102659570B (en) * 2012-05-17 2014-05-28 安润医药科技（苏州）有限公司 Difluoro fenofibrate acid and pharmaceutically acceptable salt thereof as well as preparation method and application thereof
FR3050112B1 (en) * 2016-04-15 2020-09-04 Soc Civ Immobiliere Gecinq USE OF FENOFIBRIC ACID IN THE TREATMENT OF HEPATIC DISEASES
CN107496397A (en) * 2016-06-14 2017-12-22 重庆安格龙翔医药科技有限公司 A kind of compound and its preparation of melbine and Fenofibric Acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
EP1832285A1 (en) * 2002-12-17 2007-09-12 Abbott GmbH & Co. KG Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
CN101480384A (en) * 2002-12-17 2009-07-15 阿伯特有限及两合公司 Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
EP1559419A1 (en) * 2004-01-23 2005-08-03 Fournier Laboratories Ireland Limited Pharmaceutical formulations comprising metformin and a fibrate, and processes for their obtention
US20060280790A1 (en) * 2005-04-08 2006-12-14 Ju Tzuchi R Pharmaceutical formulations

Also Published As

Publication number Publication date
ECSP099251A (en) 2009-06-30
CN101677981A (en) 2010-03-24
JP2010506855A (en) 2010-03-04
MX2009003815A (en) 2009-09-07
WO2008046052A1 (en) 2008-04-17
IL198160A0 (en) 2009-12-24
EA200900531A1 (en) 2009-12-30
SG175570A1 (en) 2011-11-28
KR20090119959A (en) 2009-11-23
CO6160302A2 (en) 2010-05-20
AU2007307641A1 (en) 2008-04-17
CA2672686A1 (en) 2008-04-17
EP2081563A1 (en) 2009-07-29

Similar Documents

Publication Publication Date Title
GB2435419B (en) Formulations
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
EP2001498A4 (en) Pharmaceutical compositions
IL194176A0 (en) Pharmaceutical compositions
EP2046930A4 (en) Rhamnolipid-based formulations
GB0625322D0 (en) Pharmaceutical compositions
EP1992348A4 (en) Pharmaceutical combination
GB0605780D0 (en) Formulations
HK1138732A1 (en) Pharmaceutical compositions
GB0614586D0 (en) Pharmaceutical Formulation
EP2112925A4 (en) Solid pharmaceutical dosage formulations
IL194366A0 (en) Solid dosage formulations
GB0718409D0 (en) Formulations
GB0610336D0 (en) Formulations
EP2002828A4 (en) Solid pharmaceutical preparation
EP2124959A4 (en) Pharmaceutical composition
IL198160A0 (en) Pharmaceutical formulations
GB0718404D0 (en) Formulations
EP1993563A4 (en) Pharmaceutical latrunculin formulations
GB0612556D0 (en) Topical pharmaceutical formulations
GB0615461D0 (en) Pharmaceutical formulations
GB0713093D0 (en) Pharmaceutical formulations
ZA200808030B (en) Pharmaceutical compositions
GB0622964D0 (en) Pharmaceutical compositions
GB0611079D0 (en) Pharmaceutical compositions